{"mainPropery":{"diseaseId":1030,"diseaseName":"Brugada syndrome","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/1030/brugada-syndrome","synonyms":["Right bundle branch block, ST segment elevation, and sudden death syndrome","Sudden unexpected nocturnal death syndrome"],"synonyms-with-source":[{"name":"Right bundle branch block, ST segment elevation, and sudden death syndrome"},{"name":"Sudden unexpected nocturnal death syndrome"}],"identifiers":[{"identifierType":"OMIM","identifierId":"601144"},{"identifierType":"ORPHANET","identifierId":"130"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":4,"diseaseTypeName":"Heart Diseases","source":"Orphanet"}],"organizations":[{"resourceID":49,"resourceName":"Sudden Arrhythmia Death Syndromes Foundation","abbreviation":"","address1":"4527 S 2300 E, Suite 104","address2":"","address3":"","address4":"","address5":"","city":"Salt Lake City","state":"UT","zip":"84117-4448 ","country":"United States","phone":"801-272-3022 ","tty":"","tollFree":"","fax":"","email":"","url":"http://www.sads.org","freeText":""},{"resourceID":475,"resourceName":"Brugada Foundation","abbreviation":"","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"info@brugada.org","url":"https://www.brugada.org/en","freeText":"Provides information in English, Castellano, and Català."}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/601144' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=brugada+syndrome%5Bti%5D+AND+(%22loattrfree+full+text%22%5Bsb%5D+AND+%222004%2F07%2F26%22%5BPDat%5D+%3A+%222009%2F07%2F24%22%5BPDat%5D+AND+English%5Blang%5D)' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Brugada syndrome. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Brugada+syndrome%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Brugada syndrome. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=brugadasyndrome' target='_blank'>MedlinePlus Genetics</a> contains information on Brugada syndrome. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":570,"resourceId":1314,"resourceName":"Identification and Treatment of Sudden Cardiac Heart Death Conditions","descriptionText":"<a href='http://breeze.mdch.train.org/bradley/ ' target='_blank'>Identification and Treatment of Sudden Death Conditions in Young Patients</a>.  A presentation by David Bradley, M.D., Director, Pediatric Heart Rhythm Service, CS Mott Children's Hospital.  Assoicate Professor, Department of Pediatrics and Communicable Diseases, University of Michigan.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Videos/Presentations"},{"id":775,"resourceId":1860,"resourceName":"Mayo Clinic","descriptionText":"<a href='http://www.mayoclinic.org/diseases-conditions/brugada-syndrome/basics/definition/con-20034848' target='_blank'>Mayo Clinic</a> has an information page on Brugada syndrome.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/CN029323' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='https://rarediseases.org/rare-diseases/brugada-syndrome/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/163751-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=130' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=brugada' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1539,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ResearchTrials_Search.php?lng=EN&type_list=researchtrials_search_simple_shd&data_id=8022&Disease(s)%20concerned=Brugada-syndrome&search=ResearchTrials_Search_Simple&ChdId=8022&ResearchTrials_ResearchTrials_Search_diseaseGroup=Brugada-syndrome&ResearchTrials_ResearchTrials_Search_diseaseType=Pat&ResearchTrials_ResearchTrials_Search_country=NN&ResearchTrials_ResearchTrials_Search_GeographicType=null' target='_blank'>Orphanet</a> lists European clinical trials, research studies, and patient registries enrolling people with this condition.&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1541,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ClinicalLabs_Search.php?lng=EN&type_list=clinicalLabs_search_simple_shd&data_id=8022&Disease(s)%20concerned=Brugada-syndrome&search=ClinicalLabs_Search_Simple&ChdId=8022&ClinicalLabs_ClinicalLabs_Search_diseaseGroup=Brugada-syndrome&ClinicalLabs_ClinicalLabs_Search_diseaseType=Pat&ClinicalLabs_ClinicalLabs_Search_country=NN&ClinicalLabs_ClinicalLabs_Search_GeographicType=null&ClinicalLabs_ClinicalLabs_Search_ClinicalLabsList_Sort=QoS' target='_blank'>Orphanet</a> lists international laboratories offering diagnostic testing for this condition.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1545,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The <a href='https://www.merckmanuals.com/home/heart-and-blood-vessel-disorders/abnormal-heart-rhythms/cardiac-channelopathies' target='_blank'>Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1700,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The&nbsp;<a href='http://www.merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/brugada-syndrome' target='_blank'>Merck Manual</a> for health care professionals provides information on&nbsp;Brugada syndrome.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1705,"resourceId":2846,"resourceName":"Project OrphanAnesthesia","descriptionText":"<a href='http://www.orphananesthesia.eu/en/rare-diseases/published-guidelines/cat_view/61-rare-diseases/60-published-guidelines/117-brugada-syndrome.html' target='_blank'>Project OrphanAnesthesia</a> is a project whose aim is to create peer-reviewed, readily accessible guidelines for patients with rare diseases and for the anesthesiologists caring for them. The project is a collaborative effort of the German Society of Anesthesiology and Intensive Care, Orphanet, the European Society of Pediatric Anesthesia, anesthetists and rare disease experts with the aim to contribute to patient safety.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:0050451' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":2366,"questionText":"What is Brugada syndrome?","answerText":"<strong>Brugada syndrome</strong> is a heart condition that causes a disruption of the normal rhythm in the heart's lower chambers (ventricular arrhythmia). Signs and symptoms usually develop in adulthood but the diagnosis may be made at any age.[1469] Symptoms and complications often occur during rest or sleep, and may include fainting, seizures, difficulty breathing, or sudden death.[1469] The underlying genetic cause of inherited forms of Brugada syndrome is not known in most cases, but in up to 20-30% of people with Brugada syndrome, it is caused by a mutation in the <em><a href=\"https://ghr.nlm.nih.gov/gene/SCN5A\" target=\"_blank\">SCN5A</a></em> gene.[15414][15415] A number of other genes have been reported to be associated with Brugada syndrome in the literature, but the role they play in causing Brugada syndrome remains to be clearly defined.[15414][15415][15416] The genetic form of Brugada syndrome typically is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner.[1469][15414] An acquired (nongenetic) form has been associated with certain drugs; abnormally high blood levels of calcium or potassium; or very low levels of potassium.[1469] In some cases, the cause of Brugada syndrome is unknown.[1469] Treatment may include use of an <a href=\"http://www.nhlbi.nih.gov/health/health-topics/topics/icd/\" target=\"_blank\">implantable cardioverter defibrillator</a> (ICD).[15414]","dateModified":"2019-09-23T00:00:00"},"basicQuestions":[{"questionId":10305,"questionText":"What are the signs and symptoms of Brugada syndrome?","answerText":"While symptoms of Brugada syndrome usually develop in adulthood, they can develop at any age. Symptoms associated with irregular heartbeat (arrhythmia) can cause fainting, seizures, difficulty breathing, or sudden death. These symptoms and complications usually occur during rest or sleep.[1469] Sudden cardiac arrest may be the initial symptom of Brugada syndrome in as many as one-third of affected people.[10948] The risk of cardiac arrest is much lower in people with no symptoms. After diagnosis, specific tests may provide an estimate of the risk of ventricular arrhythmias and sudden cardiac death in each person.[10948]","dateModified":"2016-03-16T11:07:00","resourceClassificationName":"Symptoms","references":[{"referenceId":1469,"authors":"","articleTitle":"Brugada syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"March, 2015","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=brugadasyndrome","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10948,"authors":"John V Wylie and Ann C Garlitski","articleTitle":"Brugada syndrome","bookWebsiteJournalTitle":"UpToDate","date":"February, 2016","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":7473,"questionText":"How is Brugada syndrome inherited?","answerText":"The genetic form of Brugada syndrome (not the acquired form) is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner. This means that having one mutated copy of the responsible gene in each cell is enough to cause signs or symptoms. Almost all people with Brugada syndrome have a parent with the condition. In about 1% of cases, an affected person has a new mutation in the responsible gene and has no family history of the condition. Each child of an affected person has a 50% chance to inherit the mutated gene.[7369]<br />\r\n<br />\r\nUnsymptomatic parents of an affected person should be evaluated with electrocardiography, and any family history of sudden death should be discussed. If genetic testing reveals a mutation in the affected person, genetic testing of the parents is recommended. A family history may <em>appear</em> to be negative due to reduced <a href=\"https://ghr.nlm.nih.gov/primer/inheritance/penetranceexpressivity\" target=\"_blank\">penetrance</a>, death of a parent before symptoms start, or late onset of symptoms in an affected parent.[7369]","dateModified":"2016-03-16T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":7369,"authors":"Ramon Brugada, Oscar Campuzano, Pedro Brugada, Josep Brugada, and Kui Hong","articleTitle":"Brugada Syndrome","bookWebsiteJournalTitle":"GeneReviews","date":"April 10, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1517/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4561,"questionText":"What is the long-term outlook for people with Brugada syndrome?","answerText":"The long-term outlook (prognosis) for people with Brugada syndrome varies because the condition is very unpredictable. The condition manifests primarily during adulthood, and causes a high risk of ventricular arrhythmias and sudden death. The average age of sudden death is approximately 40 years.[1469][7369]&nbsp;Affected people with a history of sudden cardiac arrest and/or fainting have an increased risk for subsequent episodes compared to people with no symptoms.[10948]","dateModified":"2016-03-16T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":1469,"authors":"","articleTitle":"Brugada syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"March, 2015","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=brugadasyndrome","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7369,"authors":"Ramon Brugada, Oscar Campuzano, Pedro Brugada, Josep Brugada, and Kui Hong","articleTitle":"Brugada Syndrome","bookWebsiteJournalTitle":"GeneReviews","date":"April 10, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1517/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10948,"authors":"John V Wylie and Ann C Garlitski","articleTitle":"Brugada syndrome","bookWebsiteJournalTitle":"UpToDate","date":"February, 2016","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12619,"relatedDiseaseName":"Arrhythmia syndrome","relation":"Parent","isRare":false,"hasGardPage":false}],"gardCases":[{"caseId":55750,"abbreviatedInquiry":"I am going into my senior year and we just figured out I have Brugada syndrome because we did testing. We just figured out that my dad had it, so I had to be tested. I play football and basketball. Do you think it would be fine for me to play these sports for my senior year?","caseQuestions":[{"questionId":10306,"questionText":"Is it safe for people with Brugada syndrome to play sports?","answerText":"<strong>We are unable to give medical advice or recommendations for management or lifestyle choices. The risk of complications and/or sudden death can differ among affected people, and recommendations for particular athletes may differ based on several factors. The type and level of activity deemed safe for one person may not be deemed safe for another. People with Brugada syndrome (or a family history) should discuss their questions about physical activity with their electrophysiologist or cardiologist for guidance. </strong><br />\r\n<br />\r\nThe literature on sudden cardiac death (SCD) during exertion has mainly focused on competitive sports.[10948] However, recreational activity limitations are also important in people with any heart disease that is commonly associated with SCD. At least some level of activity restriction is recommended for nearly all people with underlying heart disease.[10948] There is also limited information regarding the best course of management for children with Brugada syndrome.<br />\r\n<br />\r\nAccording to a <a href=\"http://circ.ahajournals.org/content/132/22/e326.full?sid=e8ddcb1f-abc3-4260-96f8-e62647cbe4a5\" target=\"_blank\">statement published in 2015 by the American Heart Association and the American College of Cardiology</a> (for competitive athletes):[10951][10969]<br />\r\n<ul>\r\n    <li>For athletes with a suspected or diagnosed cardiac channelopathy (syndrome that affects the heart's electrical system), a comprehensive evaluation by a heart rhythm specialist (electrophysiologist) or genetic cardiologist with sufficient experience and expertise with these disorders is recommended.</li>\r\n    <li>It is recommended that symptomatic athletes with any suspected or diagnosed cardiac channelopathy be restricted from all competitive sports until a comprehensive evaluation has been completed, the athlete and his or her family are well informed, a treatment program has been implemented, and the athlete has been asymptomatic on therapy for 3 months.</li>\r\n    <li>It is reasonable for an affected athlete with no signs and symptoms (with an identified genetic mutation) to participate in all competitive sports with appropriate precautionary measures, such as:\r\n    <ul>\r\n        <li>the avoidance of drugs that exacerbate Brugada syndrome;</li>\r\n        <li>avoidance of dehydration, hyperthermia (high body temperature), heat exhaustion, and heat stroke;</li>\r\n        <li>obtaining a personal, automatic, external defibrillator; and</li>\r\n        <li>establishing an emergency plan with school or team officials.</li>\r\n    </ul>\r\n    </li>\r\n    <li>In an athlete with previous symptoms, or findings of Brugada syndrome on electrocardiography, participation in competitive sports may be considered if:\r\n    <ul>\r\n        <li>precautionary measures are taken, and</li>\r\n        <li>disease-specific treatments are in place, and</li>\r\n        <li>the athlete has been asymptomatic on therapy for at least 3 months.[10969]</li>\r\n    </ul>\r\n    </li>\r\n</ul>\r\nPrevious guidelines appear to have been more restrictive. For example, for competitive athletes, the 2005 <a href=\"https://www.sads.org/images/stories/exercise/bethesda05.pdf\" target=\"_blank\">36th Bethesda Conference</a> recommended the following approach for an athlete with Brugada syndrome:[10948]<br />\r\n<ul>\r\n    <li>Although a clear association between exercise and sudden death has not been established, because of the potential impact of hyperthermia (high body temperature) and enhanced parasympathetic activity (part of the nervous system that conserves energy and slows the heart rate) induced by athletic training, restriction to participation in low-intensity sports seems advisable.</li>\r\n</ul>\r\nFor recreational athletes, the <a href=\"http://circ.ahajournals.org/content/109/22/2807.full#sec-7\" target=\"_blank\">2004 American Heart Association scientific statement</a> recommended that people with Brugada syndrome should avoid or participate cautiously in most high-intensity noncompetitive sports, including basketball, ice hockey, sprinting, and singles tennis.[10948]<br />\r\n<br />\r\nSports that cause significant risk of impaired consciousness may not be advised for people with Brugada syndrome.[10948]<br />\r\n<br />\r\n<strong>Again, people with questions about the type and level of physical activity that is safe for themselves or family members are strongly encouraged to speak with their physician.</strong>","dateModified":"2016-03-17T00:00:00","references":[{"referenceId":10948,"authors":"John V Wylie and Ann C Garlitski","articleTitle":"Brugada syndrome","bookWebsiteJournalTitle":"UpToDate","date":"February, 2016","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"},{"referenceId":10951,"authors":"Jose M Dizon","articleTitle":"Brugada Syndrome","bookWebsiteJournalTitle":"Medscape Reference","date":"December 29, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/163751-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10969,"authors":"Michael J. Ackerman, et. al","articleTitle":"Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies - A Scientific Statement From the American Heart Association and American College of Cardiology","bookWebsiteJournalTitle":"Circulation","date":"2015","volume":"132","pages":"e326-329","url":"http://circ.ahajournals.org/content/132/22/e326.full?sid=e8ddcb1f-abc3-4260-96f8-e62647cbe4a5","authors2":"","placeOfPublication":"","publisher":""}]}]},{"caseId":45123,"abbreviatedInquiry":"My 32 year old son was just diagnosed with Brugada syndrome. The cardiologist who implanted his ICD will do genetic testing I think. Is it possible to determine from my son's test whether there is a paternal or maternal link? Or does each of the parents need to be tested? My father died in his forties from cardiac arrest and his youngest sister died at age 22 from cardiac arrest.","caseQuestions":[{"questionId":7473,"questionText":"How is Brugada syndrome inherited?","answerText":"The genetic form of Brugada syndrome (not the acquired form) is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner. This means that having one mutated copy of the responsible gene in each cell is enough to cause signs or symptoms. Almost all people with Brugada syndrome have a parent with the condition. In about 1% of cases, an affected person has a new mutation in the responsible gene and has no family history of the condition. Each child of an affected person has a 50% chance to inherit the mutated gene.[7369]<br />\r\n<br />\r\nUnsymptomatic parents of an affected person should be evaluated with electrocardiography, and any family history of sudden death should be discussed. If genetic testing reveals a mutation in the affected person, genetic testing of the parents is recommended. A family history may <em>appear</em> to be negative due to reduced <a href=\"https://ghr.nlm.nih.gov/primer/inheritance/penetranceexpressivity\" target=\"_blank\">penetrance</a>, death of a parent before symptoms start, or late onset of symptoms in an affected parent.[7369]","dateModified":"2016-03-16T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":7369,"authors":"Ramon Brugada, Oscar Campuzano, Pedro Brugada, Josep Brugada, and Kui Hong","articleTitle":"Brugada Syndrome","bookWebsiteJournalTitle":"GeneReviews","date":"April 10, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1517/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7475,"questionText":"How can we learn from which parent a person inherited Brugada syndrome?","answerText":"In almost all cases, a person with Brugada syndrome inherits the condition from a parent who has a mutated copy of one of the genes responsible for the condition. In about 1% of cases, the condition results from a new (<em>de novo</em>) mutation that occurs for the first time in the affected individual.[7369]<br />\r\n<br />\r\nMutations that cause Brugada syndrome have been found in 16 different genes. However, only about 25% to 30% of cases are caused by a mutation in one of these genes (usually the <em>SCN5A</em> gene). This means that there are likely mutations in other, unidentified genes that cause Brugada syndrome.[7369] This also means that 70-75% of affected people will not test positive for a mutation when they have genetic testing.<br />\r\n<br />\r\nIf a genetic mutation is found in an affected family member, genetic testing of both parents and other at-risk relatives is appropriate.[7369] Genetic testing only in the affected person does not show where the mutation came from.<br />\r\n<br />\r\nIf a mutation in an affected person is not found, relatives should be screened with an ECG, and further testing may be needed in some cases.[7369] Attention to a family history of sudden death can be important in determining who may be at risk for the condition.[7369]<br />\r\n<br />\r\nPeople interested in learning more about the inheritance of Brugada syndrome and genetic testing should speak with a genetics professional.","dateModified":"2014-04-23T12:32:00","references":[{"referenceId":7369,"authors":"Ramon Brugada, Oscar Campuzano, Pedro Brugada, Josep Brugada, and Kui Hong","articleTitle":"Brugada Syndrome","bookWebsiteJournalTitle":"GeneReviews","date":"April 10, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1517/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2567,"questionText":"How can I find a genetics professional in my area?","answerText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by  the <a href=\"https://www.acmg.net/ACMG/Find_Genetic_Services/ACMG/ISGweb/FindaGeneticService.aspx?hkey=720856ab-a827-42fb-a788-b618b15079f9\" target=\"_blank\">American College of Medical Genetics</a>&nbsp;and the&nbsp;<a href=\"https://www.findageneticcounselor.com/\" target=\"_blank\">National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also <a href=\"http://ghr.nlm.nih.gov/handbook/consult?show=all\" target=\"_blank\">learn more about genetic consultations</a> from Genetics Home Reference.","dateModified":"2017-12-06T00:00:00","references":[]}]},{"caseId":30831,"abbreviatedInquiry":"What is the prognosis for individuals diagnosed with Brugada syndrome?","caseQuestions":[{"questionId":4561,"questionText":"What is the long-term outlook for people with Brugada syndrome?","answerText":"The long-term outlook (prognosis) for people with Brugada syndrome varies because the condition is very unpredictable. The condition manifests primarily during adulthood, and causes a high risk of ventricular arrhythmias and sudden death. The average age of sudden death is approximately 40 years.[1469][7369]&nbsp;Affected people with a history of sudden cardiac arrest and/or fainting have an increased risk for subsequent episodes compared to people with no symptoms.[10948]","dateModified":"2016-03-16T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":1469,"authors":"","articleTitle":"Brugada syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"March, 2015","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=brugadasyndrome","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7369,"authors":"Ramon Brugada, Oscar Campuzano, Pedro Brugada, Josep Brugada, and Kui Hong","articleTitle":"Brugada Syndrome","bookWebsiteJournalTitle":"GeneReviews","date":"April 10, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1517/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10948,"authors":"John V Wylie and Ann C Garlitski","articleTitle":"Brugada syndrome","bookWebsiteJournalTitle":"UpToDate","date":"February, 2016","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":9019,"phenoTypeName":"Cardiac arrest","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15472,"phenoTypeName":"Right bundle branch block","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6301,"phenoTypeName":"ST segment elevation","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9376,"phenoTypeName":"Syncope","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15465,"phenoTypeName":"First degree atrioventricular block","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9924,"phenoTypeName":"Paroxysmal ventricular tachycardia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15464,"phenoTypeName":"Sick sinus syndrome","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9927,"phenoTypeName":"Supraventricular tachycardia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8992,"phenoTypeName":"Ventricular fibrillation","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15475,"phenoTypeName":"Trifascicular block","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":9007,"phenoTypeName":"Sudden death","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Brugada_syndrome"}